Lexicon Pharmaceuticals Inc (LXRX) – cijena dionice i vijesti

Simboli Simboli	Cijena	Promjena	Postotna promjena	Trend	Prethodna zadnja	Otvori	Najviša	Najniža	Količina	Trž. kap.
SIXB Materials SIXB Materials	SIXB −0,21%	1.091,51	−2,30	−0,21%	—	1.093,81	1.096,52	1.100,22	1.091,51	—	—
SIXC Communications SIXC Communications	SIXC +0,22%	610,11	+1,34	+0,22%	—	608,77	608,77	612,97	608,77	—	—
SIXE Energy SIXE Energy	SIXE −1,34%	1.237,98	−16,83	−1,34%	—	1.254,81	1.253,01	1.253,87	1.226,33	—	—
SIXI Industrials SIXI Industrials	SIXI −0,93%	1.744,71	−16,40	−0,93%	—	1.761,11	1.764,27	1.766,88	1.744,71	—	—
SIXM Financials SIXM Financials	SIXM −0,37%	640,18	−2,40	−0,37%	—	642,58	644,87	648,48	640,18	—	—
SIXR Staples SIXR Staples	SIXR −0,18%	849,58	−1,55	−0,18%	—	851,13	855,66	858,75	845,56	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,23%	217,48	−0,50	−0,23%	—	217,98	217,98	218,65	216,88	—	—
SIXT Technology SIXT Technology	SIXT +1,52%	3.260,69	+48,86	+1,52%	—	3.211,83	3.227,21	3.268,38	3.226,55	—	—
SIXU Utilities SIXU Utilities	SIXU −0,69%	942,45	−6,53	−0,69%	—	948,98	948,58	957,83	941,97	—	—
SIXV Health care SIXV Health care	SIXV −0,52%	1.466,80	−7,72	−0,52%	—	1.474,52	1.479,03	1.481,04	1.466,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,22%	2.397,50	+5,38	+0,22%	—	2.392,12	2.396,95	2.421,22	2.382,32	—	—

LXRX:NASDAQ

Lexicon Pharmaceuticals Inc

1,63 USD

+1,24%

(+0,020) 1D

1. svi, 16:00:01 GMT -4 · USD

Svi simboli

GDD

MAKS

	Simbol	Cijena	Promjena	Postotna promjena

Generiranje najvažnijih uvida za LXRX...

Otvori

1,59 USD

Najviša

1,66 USD

Najniža

1,58 USD

Trž. kap.

690,60 mil.

Količina

0,00

52-tjed. najviša

1,95 USD

52-tjed. najniža

0,51 USD

EPS

−0,14 USD

Beta

1,27

Dionice u optjecaju

423,68 mil.

Broj djelatnika

Povezane dionice

PSTV

Plus Therapeutics Inc

6,09 USD

−0,81%

RCKT

Rocket Pharmaceuticals Inc

3,56 USD

+2,30%

IOVA

Iovance Biotherapeutics Inc

Vijesti

Iz izvora na cijelom webu

Yahoo Finance

prije 2 dana

Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851

Newser

prije 3 tjedna

Are insiders buying or selling Lexicon Pharmaceuticals (LXRX) Stock | Price at $1.60, Up 0.63% - Stock Community Signals

Profil

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Professor Allan Bradley, FRS and Professor Bradley's postdoctoral fellow Arthur T Sands. The company has used its patented mouse gene knockout technology and extensive in vivo screening capabilities to study nearly 5,000 genes in its Genome5000 program and has identified over 100 potential therapeutic targets. Lexicon has advanced multiple drug candidates into human clinical trials and has a broad and diverse pipeline of drug targets behind its clinical programs. Lexicon is pursuing drug targets in five therapeutic areas including oncology, gastroenterology, immunology, metabolism, and ophthalmology. The company's clinical drug candidates include sotagliflozin for the treatment of type 2 diabetes; LX1033 for the treatment of irritable bowel syndrome and other gastrointestinal disorders; telotristat ethyl for the treatment of the symptoms associated with carcinoid syndrome; and LX2931 for the treatment of autoimmune diseases, such as rheumatoid arthritis. Wikipedia

Lexicon Pharmaceuticals Inc – informacije

Glavni izvršni direktorLonnel Coats

Zaposlenici81

Osnovano1995

Sjedište-

Sektor-

Web-lokacijalexpharma.com

Sve vrijednosti su u valuti USD	ožu 2025.	lip 2025.	ruj 2025.	pro 2025.
Prihod	1,26 mil.	28,87 mil.	14,18 mil.	5,49 mil.
Trošak prodane robe	1,60 mil.	1,65 mil.	18,77 mil.	−43,32 mil.
Trošak prihoda	1,60 mil.	1,65 mil.	18,77 mil.	−43,32 mil.
Izdaci za istraživanje i razvoj	13,73 mil.	14,13 mil.	-	54,83 mil.
Ukupni izdaci za istraživanje i razvoj	-	-	-	-
Izdaci za prodaju, opći i administrativni izdaci	11,61 mil.	9,35 mil.	7,60 mil.	8,76 mil.
Poslovni rashod	25,34 mil.	23,48 mil.	7,60 mil.	63,59 mil.
Ukupni poslovni rashodi	26,94 mil.	25,13 mil.	26,37 mil.	20,27 mil.
Poslovni prihod	−25,68 mil.	3,74 mil.	−12,19 mil.	−14,78 mil.
Ostali neposlovni prihod	-	-	-	-
Zarada prije poreza uključujući neuobičajene stavke	−25,30 mil.	3,25 mil.	−12,77 mil.	−15,53 mil.
Zarada prije poreza isključujući neuobičajene stavke	−25,30 mil.	3,25 mil.	−12,77 mil.	−15,53 mil.
Izdaci za porez na dohodak	-	-	-	-
Efektivna porezna stopa	-	-	-	-
Ostali poslovni rashodi	-	-	-	-
Neto dohodak	−25,30 mil.	3,25 mil.	−12,77 mil.	−15,53 mil.
Neto profitna marža	−2.004,36 %	11,27 %	−90,04 %	−282,72 %
Zarada po dionici	−0,07	0,01	−0,04	−0,04
Prihod od kamata i ulaganja	2,22 mil.	1,83 mil.	1,57 mil.	1,28 mil.
Izdaci za kamate	−1,84 mil.	−2,32 mil.	−2,16 mil.	−2,03 mil.
Neto izdaci za kamate	384,00 tis.	−484,00 tis.	−582,00 tis.	−750,00 tis.
Troškovi amortizacije i otpisa	-	-	-	-
Dobit prije kamata, poreza i amortizacije	−25,50 mil.	3,91 mil.	−12,04 mil.	−14,66 mil.
Dobit ili gubitak od prodaje imovine	-	-	-	-

AI sadržaj može uključivati pogreške. Saznajte više

PomoćPošaljite povratne informacijePrivatnost Uvjeti Odricanje od odgovornosti

Finance

Istraživanje